Phase II study of a short course of weekly high-dose cisplatin combined with long-term oral etoposide in metastatic colorectal cancer.

In a phase I study of weekly administered cisplatin combined with oral etoposide, we observed a partial response in 4 out of 11 patients with metastatic colorectal cancer. Subsequently, we performed a phase II study to investigate the activity of this combination as first-line treatment in this dise...

Descripción completa

Detalles Bibliográficos
Autores principales: Planting, A. S., van der Burg, M. E., van den Bent, M. J., de Boer-Dennert, M., Stoter, G., Verweij, J.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1996
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074526/
https://www.ncbi.nlm.nih.gov/pubmed/8630290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074526/
https://www.ncbi.nlm.nih.gov/pubmed/8630290

Ejemplares similares